Clinical value and severity of myocardial perfusion defects in asymptomatic diabetic patients with negative or weakly

Seyed Rasoul Zakavi1, Mehdi Taherpour2, Zohreh Moossavi3

  • 1Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Insights

Asymptomatic type 2 diabetes patients often have mild myocardial perfusion defects, detectable by exercise treadmill testing and myocardial perfusion imaging. These findings, while common, do not predict adverse cardiac events in the short term.

Area of Science:

  • Cardiology
  • Diabetology
  • Nuclear Medicine

Background:

  • Coronary artery disease (CAD) is a major cause of mortality in type 2 diabetes mellitus (T2DM).
  • Diabetic patients with CAD often remain asymptomatic.
  • Myocardial perfusion imaging (MPI) can detect ischemia in asymptomatic individuals.

Purpose of the Study:

  • To investigate the prevalence and severity of myocardial perfusion defects in asymptomatic T2DM patients.
  • To assess the clinical impact of these defects on cardiac events.

Main Methods:

  • 130 asymptomatic T2DM patients (age 35-65) without prior CAD underwent echocardiography, ECG, lab tests, and exercise treadmill test (ETT).
  • Patients with non-negative ETT results had Dipyridamole MPI; positive ETT led to coronary angiography.
  • Follow-up for cardiac events was conducted for at least 17 months.

Main Results:

  • 74.3% had negative ETT, 15% weakly positive, 10.7% positive. Angiography confirmed CAD in 75% of positive ETT patients.
  • MPI revealed reversible defects in 26.9% of patients, with a mean summed stress score of 3.3±1.8.
  • Higher blood glucose, HbA1c, TG/HDL ratio, and end-diastolic volume were associated with ischemia.

Conclusions:

  • Reversible myocardial perfusion defects are common in asymptomatic T2DM patients but are typically mild.
  • These defects did not correlate with adverse cardiac events during the follow-up period.
  • Standard CAD detection using ETT followed by MPI is appropriate for asymptomatic T2DM patients.
Abstract